NextCell publishes its Year-End Report 2021/2022
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Year-End Report for the period September 1, 2021 – August 31, 2022 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Fourth quarter (2022-06-01 until 2022-08-31) ● Operating income amounted to 1 405 (1 381) TSEK. ● Operating result amounted to -8 563 (-4 457) TSEK. ● Earnings per share* amounted to